CLINICAL STUDY: Predicting the effect of naltrexone and acamprosate in alcohol‐dependent patients using genetic indicators
Year: 2009
Type: article
Study design: Clinical Trial
Source: Addiction Biology
Institutions: San Francisco VA Medical Center, University of California, San Francisco, Amsterdam UMC Location University of Amsterdam, Amsterdam Institute for Addiction Research, University of Amsterdam, Inserm, Groupe de Recherche sur l'Alcool et les Pharmacodépendances, Université de Picardie Jules Verne, De Viersprong
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1585479090
